Description

Thymalfasin is a synthetic analog of the thymic hormone Thymosin ??1, a 28?amino?acid peptide known to modulate the immune system by enhancing T-cell function, NK cell activity, and cytokine production. It supports research in viral infections, immunodeficiency models, cancer immunotherapy, and vaccine efficacy. The injectable form with provided solvent ensures precise dosing and reproducible results in preclinical assays.

Thymalfasin Injection Product Specifications

Thymalfasin Injection Mechanism of Action

Thymosin ??1 binds cell-surface receptors to modulate immune signaling, promoting T-cell maturation, NK cell activity, dendritic cell function, and balanced cytokine production. It ensures enhanced adaptive and innate immune responses in various disease and vaccine models.

Thymalfasin Injection Research Applications

• Immunomodulation in viral infection models

• Adjuvant effects in vaccine development and studies

• Cancer immunotherapy and checkpoint modulation

• Immune deficiency and sepsis model testing

• Combination research with antiviral agents, cytokines, or vaccines

Safety & Handling

• Handling: Use sterile technique with gloves and eyewear. Prepare under aseptic conditions.

• Storage: Keep refrigerated at 2–8?°C. Discard if freeze-thawed or contaminated.

• Precautions: Use only under approved laboratory protocols; not for human or veterinary injection.

Core Keywords

Thymalfasin injection, thymosin alpha-1 1.6mg, H20133153, immune modulation peptide, laboratory thymalfasin, wholesale thymosin peptide injection

Research Use Disclaimer

This product is strictly for laboratory and preclinical research use. It is not approved for medical, diagnostic, therapeutic, or veterinary use. Misuse may pose legal or health risks. Use only under institutional protocols and regulatory guidelines.